As of April 2024 KYORIN Pharmaceutical has a market cap of $0.66 Billion. This makes KYORIN Pharmaceutical the world's 5639th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.66 B | -8.28% |
2023 | $0.72 B | -2.45% |
2022 | $0.74 B | -19.34% |
2021 | $0.91 B | -14.74% |
2020 | $1.07 B | 7.35% |
2019 | $1.00 B | -20.62% |
2018 | $1.26 B | -8.02% |
2017 | $1.37 B | -13.4% |
2016 | $1.58 B | 2.19% |
2015 | $1.55 B | 11.11% |
2014 | $1.39 B | -12.78% |
2013 | $1.60 B | 10.12% |
2012 | $1.45 B | 11.73% |
2011 | $1.30 B | -0.01% |
2010 | $1.30 B | 18.79% |
2009 | $1.09 B | 3.98% |
2008 | $1.05 B | 29.02% |
2007 | $0.81 B |
On Apr 26th, 2024 the market cap of KYORIN Pharmaceutical was reported to be: